SLC6A1 Disorder Review Covers Symptoms And New Treatments
This paper was a scoping review, which means the authors gathered and summarized published research rather than testing a treatment in one new group of patients.
This paper was a scoping review, which means the authors gathered and summarized published research rather than testing a treatment in one new group of patients.
Researchers developed and independently validated a computer model to estimate whether a person with epilepsy would respond to valproic acid (VPA), a common first-line antiseizure medicine.
Researchers followed 12 adults with Down syndrome who had progressive myoclonus epilepsy in the setting of Alzheimer’s disease.
This study looked at sleep problems in people with KCNB1-related disorders, a genetic condition that can involve epilepsy, developmental difficulties, or both.
This study looked at whole-exome sequencing in 1,109 children with epilepsy at a single medical center.
This study looked at whether people with active epilepsy or inactive epilepsy were meeting aerobic exercise guidelines, and whether neighborhood social cohesion was related to this association.
This study looked at how adults with non-convulsive status epilepticus (NCSE) were treated in a 6-year ambispective registry, and whether treatment patterns were associated with seizure control, death in the hospital, or worse function at discharge.
Researchers looked at whether a brain signal called the corticocortical evoked potential, or CCEP, changes right away after brief brain stimulation in people with drug-resistant epilepsy.
This study looked at how often genetic testing finds a clear epilepsy-related cause in adults being evaluated for epilepsy surgery.